LYRA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Lyra Therapeutics Inc (LYRA).


$13.51M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

LYRA Market Cap. (MRY)


LYRA Shares Outstanding (MRY)


LYRA Assets (MRY)


Total Assets

$66.35M

Total Liabilities

$54.75M

Total Investments

$0

LYRA Income (MRY)


Revenue

$1.53M

Net Income

-$93.44M

Operating Expense

$97.88M

LYRA Cash Flow (MRY)


CF Operations

-$70.01M

CF Investing

$80.31M

CF Financing

$8.53M

LYRA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

LYRA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$66,346,000 (-53.47%)

$142,600,000 (29.67%)

$109,968,000 (100.43%)

$54,867,000 (-32.12%)

Assets Current

$43,025,000 (-58.95%)

$104,821,000 (3.96%)

$100,829,000 (110.42%)

$47,918,000 (-36.88%)

Assets Non-Current

$23,321,000 (-38.27%)

$37,779,000 (313.38%)

$9,139,000 (31.52%)

$6,949,000 (41.44%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$11,594,000 (-87.03%)

$89,420,000 (10.73%)

$80,754,000 (135.32%)

$34,316,000 (-53.93%)

Property Plant & Equipment Net

$21,328,000 (-39.54%)

$35,276,000 (689.88%)

$4,466,000 (-23.76%)

$5,858,000 (31.17%)

Cash & Equivalents

$42,570,000 (79.28%)

$23,745,000 (-30.04%)

$33,942,000 (-26.33%)

$46,076,000 (-38.50%)

Accumulated Other Comprehensive Income

$0 (0%)

$33,000 (230.00%)

$10,000 (0%)

$0 (0%)

Deferred Revenue

$12,260,000 (-11.12%)

$13,794,000 (-10.15%)

$15,352,000 (31.05%)

$11,715,000 (0%)

Total Investments

$0 (0%)

$80,400,000 (23.04%)

$65,344,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$80,400,000 (23.04%)

$65,344,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,179,000 (-62.34%)

$3,131,000 (19.69%)

$2,616,000 (-16.29%)

$3,125,000 (238.94%)

Accumulated Retained Earnings (Deficit)

-$404,790,000 (-30.01%)

-$311,355,000 (-25.21%)

-$248,675,000 (-28.58%)

-$193,397,000 (-29.03%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$34,380,000 (27.90%)

$26,881,000 (1113.04%)

$2,216,000 (52.51%)

$1,453,000 (-40.43%)

Debt Current

$4,121,000 (-24.16%)

$5,434,000 (250.81%)

$1,549,000 (44.23%)

$1,074,000 (9.04%)

Debt Non-Current

$30,259,000 (41.09%)

$21,447,000 (3115.44%)

$667,000 (75.99%)

$379,000 (-73.93%)

Total Liabilities

$54,752,000 (2.96%)

$53,180,000 (82.04%)

$29,214,000 (42.15%)

$20,551,000 (224.25%)

Liabilities Current

$12,631,000 (-35.55%)

$19,597,000 (35.43%)

$14,470,000 (-20.69%)

$18,246,000 (273.59%)

Liabilities Non-Current

$42,121,000 (25.42%)

$33,583,000 (127.77%)

$14,744,000 (539.65%)

$2,305,000 (58.53%)

LYRA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,534,000 (-1.54%)

$1,558,000 (14.31%)

$1,363,000 (378.25%)

$285,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$18,501,000 (-2.92%)

$19,057,000 (8.55%)

$17,556,000 (23.58%)

$14,206,000 (46.65%)

Research & Development Expense

$43,766,000 (-8.88%)

$48,029,000 (23.80%)

$38,797,000 (30.66%)

$29,694,000 (137.13%)

Operating Expenses

$97,882,000 (42.52%)

$68,678,000 (19.09%)

$57,669,000 (31.36%)

$43,900,000 (97.67%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$39,000 (-33.90%)

$59,000 (353.85%)

$13,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$93,435,000 (-49.07%)

-$62,680,000 (-13.39%)

-$55,278,000 (-27.04%)

-$43,513,000 (-96.65%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$93,435,000 (-49.07%)

-$62,680,000 (-13.39%)

-$55,278,000 (-27.04%)

-$43,513,000 (-96.65%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$93,435,000 (-49.07%)

-$62,680,000 (-13.39%)

-$55,278,000 (-27.04%)

-$43,513,000 (-96.65%)

Weighted Average Shares

$65,113,859 (30.74%)

$49,804,283 (64.72%)

$30,235,689 (132.83%)

$12,986,101 (51.17%)

Weighted Average Shares Diluted

$65,113,859 (30.74%)

$49,804,283 (64.72%)

$30,235,689 (132.83%)

$12,986,101 (51.17%)

Earning Before Interest & Taxes (EBIT)

-$93,396,000 (-49.14%)

-$62,621,000 (-13.31%)

-$55,265,000 (-27.01%)

-$43,513,000 (-96.65%)

Gross Profit

$1,534,000 (-1.54%)

$1,558,000 (14.31%)

$1,363,000 (378.25%)

$285,000 (0%)

Operating Income

-$96,348,000 (-43.55%)

-$67,120,000 (-19.21%)

-$56,306,000 (-29.10%)

-$43,615,000 (-96.38%)

LYRA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$80,305,000 (738.15%)

-$12,584,000 (80.64%)

-$65,006,000 (-1820.41%)

-$3,385,000 (-90.70%)

Net Cash Flow from Financing

$8,531,000 (-87.01%)

$65,691,000 (-31.75%)

$96,257,000 (26712.53%)

$359,000 (-99.59%)

Net Cash Flow from Operations

-$70,011,000 (-10.59%)

-$63,304,000 (-45.91%)

-$43,385,000 (-68.03%)

-$25,820,000 (-22.12%)

Net Cash Flow / Change in Cash & Cash Equivalents

$18,825,000 (284.61%)

-$10,197,000 (15.96%)

-$12,134,000 (57.94%)

-$28,846,000 (-144.53%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$82,643,000 (816.33%)

-$11,537,000 (82.21%)

-$64,842,000 (0%)

$0 (0%)

Capital Expenditure

-$2,338,000 (-123.30%)

-$1,047,000 (-538.41%)

-$164,000 (95.16%)

-$3,385,000 (-90.70%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$8,821,000 (-87.28%)

$69,345,000 (-31.00%)

$100,503,000 (16539.57%)

$604,000 (-98.95%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,716,000 (14.08%)

$5,887,000 (8.08%)

$5,447,000 (96.64%)

$2,770,000 (52.79%)

Depreciation Amortization & Accretion

$471,000 (69.42%)

$278,000 (-73.95%)

$1,067,000 (6.59%)

$1,001,000 (953.68%)

LYRA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-6090.90% (-51.40%)

-4023.10% (0.80%)

-4055.60% (73.44%)

-15267.70%

EBITDA Margin

-6057.70% (-51.39%)

-4001.50% (-0.63%)

-3976.40% (73.34%)

-14916.50%

Return on Average Equity (ROAE)

-265.60% (-258.43%)

-74.10% (-1.65%)

-72.90% (13.52%)

-84.30% (-9.91%)

Return on Average Assets (ROAA)

-98.00% (-88.82%)

-51.90% (4.60%)

-54.40% (15.00%)

-64.00% (-118.43%)

Return on Sales (ROS)

-6088.40% (-51.48%)

-4019.30% (0.87%)

-4054.70% (73.44%)

-15267.70%

Return on Invested Capital (ROIC)

-109.90% (-41.99%)

-77.40% (82.47%)

-441.50% (-118.36%)

2404.70% (501.32%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.14 (96.54%)

-4.16 (-142.37%)

-1.72 (-31.90%)

-1.3 (70.45%)

Price to Sales Ratio (P/S)

8.76 (-94.77%)

167.51 (140.48%)

69.66 (-64.94%)

198.66

Price to Book Ratio (P/B)

1.17 (-62.18%)

3.08 (148.79%)

1.24 (-25.06%)

1.65 (-16.48%)

Debt to Equity Ratio (D/E)

4.72 (693.61%)

0.59 (64.36%)

0.36 (-39.57%)

0.6 (604.71%)

Earnings Per Share (EPS)

-1.43 (-13.49%)

-1.26 (31.15%)

-1.83 (45.37%)

-3.35 (-29.34%)

Sales Per Share (SPS)

0.02 (-22.58%)

0.03 (-31.11%)

0.04 (104.55%)

0.02 (0%)

Free Cash Flow Per Share (FCFPS)

-1.11 (14.01%)

-1.29 (10.28%)

-1.44 (35.97%)

-2.25 (15.70%)

Book Value Per Share (BVPS)

0.18 (-90.08%)

1.79 (-32.80%)

2.67 (1.06%)

2.64 (-69.52%)

Tangible Assets Book Value Per Share (TABVPS)

1.02 (-64.41%)

2.86 (-21.28%)

3.64 (-13.92%)

4.22 (-55.10%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-4 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.25 (93.95%)

-4.1 (-2234.38%)

0.19 (19100.00%)

0 (100.03%)

Asset Turnover

0.02 (23.08%)

0.01 (0.00%)

0.01 (225.00%)

0 (0%)

Current Ratio

3.41 (-36.32%)

5.35 (-23.23%)

6.97 (165.35%)

2.63 (-83.11%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$72,349,000 (-12.43%)

-$64,351,000 (-47.77%)

-$43,549,000 (-49.11%)

-$29,205,000 (-27.43%)

Enterprise Value (EV)

$23,042,459 (-90.98%)

$255,478,785 (2560.74%)

-$10,382,195 (-19850.41%)

-$52,040 (-100.08%)

Earnings Before Tax (EBT)

-$93,396,000 (-49.14%)

-$62,621,000 (-13.31%)

-$55,265,000 (-27.01%)

-$43,513,000 (-96.65%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$92,925,000 (-49.05%)

-$62,343,000 (-15.03%)

-$54,198,000 (-27.49%)

-$42,512,000 (-92.96%)

Invested Capital

$45,525,000 (-63.91%)

$126,139,000 (97.80%)

$63,772,000 (896.95%)

-$8,002,000 (-331.07%)

Working Capital

$30,394,000 (-64.34%)

$85,224,000 (-1.31%)

$86,359,000 (191.05%)

$29,672,000 (-58.23%)

Tangible Asset Value

$66,346,000 (-53.47%)

$142,600,000 (29.67%)

$109,968,000 (100.43%)

$54,867,000 (-32.12%)

Market Capitalization

$13,510,459 (-95.09%)

$275,430,785 (175.60%)

$99,936,805 (76.26%)

$56,699,960 (-61.52%)

Average Equity

$35,173,500 (-58.41%)

$84,581,750 (11.48%)

$75,870,500 (46.93%)

$51,638,500 (78.92%)

Average Assets

$95,302,750 (-21.03%)

$120,679,500 (18.66%)

$101,702,750 (49.63%)

$67,969,500 (-9.87%)

Invested Capital Average

$84,972,000 (5.09%)

$80,855,000 (545.90%)

$12,518,250 (791.81%)

-$1,809,500 (-149.00%)

Shares

65,457,648 (24.53%)

52,563,127 (65.15%)

31,827,008 (144.74%)

13,004,578 (0.60%)